Literature DB >> 10878017

A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice.

D E Sabatino1, C Wong, A P Cline, L Pyle, L J Garrett, P G Gallagher, D M Bodine.   

Abstract

In red blood cells ankyrin (ANK-1) provides the primary linkage between the erythrocyte membrane skeleton and the plasma membrane. We have previously demonstrated that a 271-bp 5'-flanking region of the ANK-1 gene has promoter activity in erythroid, but not non-erythroid, cell lines. To determine whether the ankyrin promoter could direct erythroid-specific expression in vivo, we analyzed transgenic mice containing the ankyrin promoter fused to the human (A)gamma-globin gene. Sixteen of 17 lines expressed the transgene in erythroid cells indicating nearly position-independent expression. We also observed a significant correlation between the level of Ank/(A)gamma-globin mRNA and transgene copy number. The level of Ank/(A)gamma mRNA averaged 11% of mouse alpha-globin mRNA per gene copy at all developmental stages. The addition of the HS2 enhancer from the beta-globin locus control region to the Ank/(A)gamma-globin transgene resulted in Ank/(A)gamma-globin mRNA expression in embryonic and fetal erythroid cells in six of eight lines but resulted in absent or dramatically reduced levels of Ank/(A)gamma-globin mRNA in adult erythroid cells in eight of eight transgenic lines. These data indicate that the minimal ankyrin promoter contains all sequences necessary and sufficient for erythroid-specific, copy number-dependent, position-independent expression of the human (A)gamma-globin gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878017     DOI: 10.1074/jbc.M004043200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis.

Authors:  Patrick G Gallagher; Laurie A Steiner; Robert I Liem; Ashley N Owen; Amanda P Cline; Nancy E Seidel; Lisa J Garrett; David M Bodine
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

2.  An insulator with barrier-element activity promotes alpha-spectrin gene expression in erythroid cells.

Authors:  Patrick G Gallagher; Douglas G Nilson; Laurie A Steiner; Yelena D Maksimova; Jolinta Y Lin; David M Bodine
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

3.  Functional analysis of a novel cis-acting regulatory region within the human ankyrin gene (ANK-1) promoter.

Authors:  Karina Laflamme; Ashley N Owen; Emily E Devlin; Mary Q Yang; Clara Wong; Laurie A Steiner; Lisa J Garrett; Laura Elnitski; Patrick G Gallagher; David M Bodine
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

Review 4.  Gene therapy for sickle cell disease: An update.

Authors:  Selami Demirci; Naoya Uchida; John F Tisdale
Journal:  Cytotherapy       Date:  2018-05-30       Impact factor: 5.414

5.  Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genes.

Authors:  Laurie A Steiner; Yelena Maksimova; Vincent Schulz; Clara Wong; Debasish Raha; Milind C Mahajan; Sherman M Weissman; Patrick G Gallagher
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

6.  Altered regulation of beta-like globin genes by a redesigned erythroid transcription factor.

Authors:  Deepa Manwani; Mariann Galdass; James J Bieker
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

7.  Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter.

Authors:  D E Sabatino; N E Seidel; G J Aviles-Mendoza; A P Cline; S M Anderson; P G Gallagher; D M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

8.  Variegated expression from the murine band 3 (AE1) promoter in transgenic mice is associated with mRNA transcript initiation at upstream start sites and can be suppressed by the addition of the chicken beta-globin 5' HS4 insulator element.

Authors:  Tiffany F Frazar; Jessica L Weisbein; Stacie M Anderson; Amanda P Cline; Lisa J Garrett; Gary Felsenfeld; Patrick G Gallagher; David M Bodine
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

9.  Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome.

Authors:  Daren Wang; Wei Zhang; Theodosia A Kalfa; Gregory Grabowski; Stella Davies; Punam Malik; Dao Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-10       Impact factor: 11.205

Review 10.  Gene therapy for hemoglobinopathies: progress and challenges.

Authors:  Alisa Dong; Stefano Rivella; Laura Breda
Journal:  Transl Res       Date:  2013-01-19       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.